NYSE:BMY   Bristol-Myers Squibb Company
Healthy pipeline.

Sitting at 3.32% yield and 8.62 P/E (norm is 18.65 and 5Y norm is 11.17) with earnings growth rate approx. 6.18% since 2000 but has increased to 15-16% if you look at the 10Y and 5Y norms.

Estimates are for about 4-6% the next 2 years.

A+ Credit Rating
48LT Debt to Cap

PT $96 by 2023 using a 7% earnings growth rate and 12 P/E

HUGE saucer pattern -- technically.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.